DJIA 16,868.16 -174.74 -1.03%
NASDAQ 4,447.80 -45.59 -1.01%
S&P 500 1,956.14 -16.15 -0.82%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

58.80 -0.48 (-0.81%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $58.77 -0.86%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.09
Previous Close $59.28
Daily Range $58.76 - $59.22
52-Week Range $44.62 - $61.33
Market Cap $169.6B
P/E Ratio 31.20
Dividend (Yield) $1.76 (3.0%)
Ex-Dividend Date
Dividend Pay Date
09/11/14
10/07/14
Volume 3,509,967
Average Daily Volume 8,387,508
Current FY EPS $3.49

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Big News for These 5 Stocks From ESMO

But smaller biotechs Clovis Oncology and Exelixis also benefit from the big boys' data.

Noteworthy ETF Inflows: HDV, T, VZ, MRK

As Ebola spreads, drug stocks surge

Ebola drug stocks surge as virus spreads to U.S.

Johnson & Johnson Is The Most Attractive Mega-Cap Pharma Stock For Income Investors

The ominous volatility burst and a trend to consider when picking those shorts

Bristol-Myers' Opdivo Under Review in US, EU for Cancer Treatment - Analyst Blog

Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog

Indian Prime Minister courts U.S. CEOs

Why Endocyte, Inc. Stock Briefly Spiked Higher

Endocyte stock was briefly among today's top gainers after the company released an encouraging interim update on experimental drug vintafolide as a possible non-small cell lung cancer treatment.

Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader

See More MRK News...

MRK's Top Competitors

MRK $58.80 (-0.81%)
Current stock: MRK
JNJ $104.36 (-2.09%)
Current stock: JNJ
NVS $93.45 (-0.72%)
Current stock: NVS
RHHBY $36.94 (-0.14%)
Current stock: RHHBY